Biosynthesis of the Plant Coumarin Osthole by Engineered Saccharomyces cerevisiae
ACS Synthetic Biology · 18.08.2023 · 12 (8) · 2455-2462
DOI: 10.1021/acssynbio.3c00321 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Synthetic Biology, online erschienen am 14.07.2023. Verfasst von Pingping Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: CAS-Key Laboratory of Synthetic Biology, CAS Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, Shanghai 200032, China. Hauptthemen laut MEDLINE: Saccharomyces cerevisiae, Coumarins. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Chinese Academy of Sciences.
Abstract (Originalsprache)
Osthole is a coumarin compound found in the traditional Chinese medicine Cnidium monnieri. Extensive studies have shown that osthole exhibits many medicinal properties, and recently, researchers have found that it possesses potent airway-relaxation activity by inhibiting phosphodiesterase 4D activity, making it a potential novel bronchodilator that does not target β2-adrenoceptors for asthma treatment. Here, we report the complete biosynthesis of osthole in engineered yeast. We created an umbelliferone (UMB)-producing strain by reconstituting the complete UMB pathway in yeast. We found that coumarin synthase (COSY) is essential for the conversion of 2',4'-dihydroxycinnamoyl-CoA into UMB in yeast; this conversion has been treated as a spontaneous step in previously reported UMB-producing microbials. By introducing downstream prenyltransferase and methyltransferase genes and addressing problems such as protein expression and cofactor supply to fulfill the downstream steps, complete biosynthesis of osthole was achieved. Finally, through metabolic engineering, to ensure precursor supply, and the debugging of rate-limited steps, the osthole titer reached 108.10 mg/L in shake flasks and 255.1 mg/L in fed-batch fermentation. Our study is the first to produce osthole using engineered microbes, providing a blueprint for the supply of plant-derived osthole via microbial fermentation, which will remove the barriers of resource limitations for osthole-based drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CAS-Key Laboratory of Synthetic Biology, CAS Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, Shanghai 200032, China.
- University of Chinese Academy of Sciences, Beijing 100049, China.
ORCID-Profile: Pingping Wang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Chinese Academy of Sciences
Zitieren
APA
Wang, P., Fan, Z., Wei, W., Yang, C., Wang, Y., Shen, X., Yan, X., & Zhou, Z. (2023). Biosynthesis of the Plant Coumarin Osthole by Engineered Saccharomyces cerevisiae. ACS Synthetic Biology, 12(8), 2455-2462. https://doi.org/10.1021/acssynbio.3c00321
Vancouver
Wang P, Fan Z, Wei W, Yang C, Wang Y, Shen X, et al. Biosynthesis of the Plant Coumarin Osthole by Engineered Saccharomyces cerevisiae. ACS Synthetic Biology. 2023;12(8):2455-2462. doi:10.1021/acssynbio.3c00321
BibTeX
@article{Wang2023,
author = {Wang, Pingping and Fan, Zhenjun and Wei, Wenping and Yang, Chengshuai and Wang, Yan and Shen, Xiao and Yan, Xing and Zhou, Zhihua},
title = {Biosynthesis of the Plant Coumarin Osthole by Engineered Saccharomyces cerevisiae},
journal = {ACS Synthetic Biology},
year = {2023},
volume = {12},
number = {8},
pages = {2455--2462},
doi = {10.1021/acssynbio.3c00321}
}
EUVIMED